Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
FQuintero (talk | contribs)
editor
355 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(19 intermediate revisions by 4 users not shown)
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|Contacted author to clarify 2 references - MS 03/02/21
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
Line 834: Line 834:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Disease
|Helene Bruyere
|Chenkai Ma
|
|
|
|
Line 877: Line 886:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
| ||Snehal Patel (SP)
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Snehal Patel
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
| || ||
|
|
|
|
|Complete
|
|
|SP
| ||
|
|
|
|
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|Complete
|
|
|SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 947: Line 957:
|
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 956: Line 966:
|
|
|-
|-
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 965: Line 975:
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 974: Line 984:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 983: Line 993:
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease||
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|PENDING
| ||SP
|
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
|
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
Line 1,032: Line 1,038:
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|    Mu Heavy Chain Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasmacytoma||Disease||
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|
|
|PENDING
|Complete
|
|5/26/2021||SP
|SP
|
|
|
|
|-
|-
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|    Alpha Heavy Chain Disease||Disease||
|
|
|
|
Line 1,076: Line 1,078:
|
|
|-
|-
|           Primary  Amyloidosis||Disease||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease||
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|3/9/21
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|           Primary  Amyloidosis||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|Complete
| ||SP
|11/11/2020
|SP
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|         POEMS Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|         TEMPI Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|
|3/9/21
|
|
|PENDING
|PENDING
Line 1,178: Line 1,180:
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|
|Complete
|Complete
|8/16/2020
|5/28/2021||SP
|SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|9/30/20
|Complete
|PENDING
|11/11/2020
| ||SP
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|
|8/15/20
|PENDING
|PENDING
|
|
Line 1,212: Line 1,215:
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,221: Line 1,224:
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease||
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,230: Line 1,233:
|
|
|-
|-
| || ||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
| ||
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|PENDING
|PENDING
|
| ||SP
|Greg Corboy (GC)
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|
|
|SP
| ||GC
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
| || ||
|
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
| ||GC
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,295: Line 1,310:
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
Line 1,303: Line 1,318:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
Line 1,311: Line 1,326:
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
|
Line 1,319: Line 1,334:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
Line 1,327: Line 1,342:
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
|
Line 1,335: Line 1,350:
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
Line 1,351: Line 1,366:
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,359: Line 1,374:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,367: Line 1,382:
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,375: Line 1,390:
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
Line 1,391: Line 1,406:
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,399: Line 1,414:
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
Line 1,407: Line 1,422:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
Line 1,415: Line 1,430:
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
Line 1,423: Line 1,438:
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|
|3/11/21
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|
|
|-
|-
| || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
| ||GC
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||
| || ||
|
|
|
|
|
|
| ||SP
| ||
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
Line 1,495: Line 1,510:
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
Line 1,519: Line 1,534:
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
Line 1,527: Line 1,542:
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
Line 1,580: Line 1,599:
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
Line 1,589: Line 1,608:
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,758: Line 1,813:
|
|
|
|
| ||Associate Editor??
| ||Greg Corboy (GC)
|
|
|
|
Line 1,766: Line 1,821:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,774: Line 1,829:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,782: Line 1,837:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,790: Line 1,845:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,798: Line 1,853:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,806: Line 1,861:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,814: Line 1,869:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,822: Line 1,877:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,830: Line 1,885:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,838: Line 1,893:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,849: Line 1,904:
|PENDING
|PENDING
|
|
|
|GC
|
|
|
|
Line 1,857: Line 1,912:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,865: Line 1,920:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,873: Line 1,928:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,881: Line 1,936:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,889: Line 1,944:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,897: Line 1,952:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,905: Line 1,960:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,913: Line 1,968:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,921: Line 1,976:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,929: Line 1,984:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,937: Line 1,992:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,945: Line 2,000:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,953: Line 2,008:
|
|
|
|
| ||
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
| ||GC
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||
|
|
|
|
Line 2,701: Line 2,756:
|
|
|-
|-
|
|BRCA1
|
|
|
|
Line 2,711: Line 2,766:
|
|
|-
|-
|
|BRCA2
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"